7 research outputs found
Brote urbano de aguda adquirida por vÃa oral la enfermedad de Chagas en el estado Táchira, Venezuela
Aguda por vÃa oral adquirió la enfermedad de Chagas (AOACD) se ha convertido en una amenaza importante en algunos paÃses de América del Sur [1,2]. Hasta marzo de 2013, al menos cuatro han reportado brotes de la enfermedad de Chagas aguda adquirida por vÃa oral, en concreto Brasil [3], Venezuela [4], Colombia [5] y Bolivia [6]. Los brotes también se están produciendo probablemente en Argentina y Ecuador, según algunos informes antiguos [2]. En Venezuela, ha habido por lo menos tres informes epidemiológicos conocidos de AOACD, la primera en 2007 en Caracas (Chacao) [4], el segundo en 2009 a Vargas [7] y la tercera en 2010 en Caracas (AntÃmano) [ 8]. Una caracterÃstica común de estos brotes es que han afectado principalmente a los niños y han dado lugar a una alta tasa de mortalidad entre los casos confirmados. Los informes que describen la investigación de estos brotes son de gran importancia cientÃfica y epidemiológica, sin embargo, la información sólo en el primer brote se ha publicado [4]. Por estas razones, se reportan los resultados del cuarto brote de AOACD que ocurrió en Venezuela, en el estado de Táchira.Acute orally acquired Chagas disease (AOACD) has emerged as a significant threat in some countries
of South America [1,2]. Until March 2013, at least
four have reported outbreaks of acute orally acquired Chagas disease, specifically Brazil [3], Venezuela [4], Colombia [5] and Bolivia [6]. Outbreaks are also likely occurring in Argentina and Ecuador, according to some old reports [2]. In Venezuela, there have been at least three well-known epidemiological reports of AOACD, the first in 2007 at Caracas (Chacao) [4], the second in 2009 at Vargas [7] and the third in 2010 at
Caracas (Antimano) [8]. A common feature of these
outbreaks is that they have affected predominantly
children and have led to a high fatality rate among confirmed cases. Reports describing the investigation of these outbreaks are of high scientific and epidemiological significance; however, information on only the first outbreak has been published [4]. For these reasons we report the findings of the fourth outbreak of AOACD that occurred in Venezuela, in Táchira state
Infectious Diseases, Social, Economic and Political Crises, Anthropogenic Disasters and Beyond: Venezuela 2019 – Implications for Public Health and Travel Medicine
During last months, there have been a significant increase in the evidences showing the catastrophic health situation in Venezuela. There are multiple epidemics, increase in emerging and reemerging infectious, tropical and parasitic diseases as consequences of the social, economic and political crises, which would be considered today a clearly anthropogenic disaster. Venezuela is facing in 2019, the worse sanitary conditions, with multiple implications for public health and travel medicine. So far, from a global perspective, this situation will be an impediment for the achievement of the sustainable development goals (SDG) in 2030. In this multiauthor review, there is a comprehensive analysis of the situation for infectious diseases, non-communicable diseases, their impact in the Americas region, given the migration crisis as well as the comparative status of the SDG 2030. This discussion can provide input for prioritizing emerging health problems and establish a future agenda
Infectious Diseases, Social, Economic and Political Crises, Anthropogenic Disasters and Beyond: Venezuela 2019 – Implications for Public Health and Travel Medicine
During last months, there have been a significant increase in the evidences showing the catastrophic health situation in Venezuela. There are multiple epidemics, increase in emerging and reemerging infectious, tropical and parasitic diseases as consequences of the social, economic and political crises, which would be considered today a clearly anthropogenic disaster. Venezuela is facing in 2019, the worse sanitary conditions, with multiple implications for public health and travel medicine. So far, from a global perspective, this situation will be an impediment for the achievement of the sustainable development goals (SDG) in 2030. In this multiauthor review, there is a comprehensive analysis of the situation for infectious diseases, non-communicable diseases, their impact in the Americas region, given the migration crisis as well as the comparative status of the SDG 2030. This discussion can provide input for prioritizing emerging health problems and establish a future agenda
Brote urbano de aguda adquirida por vÃa oral la enfermedad de Chagas en el estado Táchira, Venezuela
Aguda por vÃa oral adquirió la enfermedad de Chagas (AOACD) se ha convertido en una amenaza importante en algunos paÃses de América del Sur [1,2]. Hasta marzo de 2013, al menos cuatro han reportado brotes de la enfermedad de Chagas aguda adquirida por vÃa oral, en concreto Brasil [3], Venezuela [4], Colombia [5] y Bolivia [6]. Los brotes también se están produciendo probablemente en Argentina y Ecuador, según algunos informes antiguos [2]. En Venezuela, ha habido por lo menos tres informes epidemiológicos conocidos de AOACD, la primera en 2007 en Caracas (Chacao) [4], el segundo en 2009 a Vargas [7] y la tercera en 2010 en Caracas (AntÃmano) [ 8]. Una caracterÃstica común de estos brotes es que han afectado principalmente a los niños y han dado lugar a una alta tasa de mortalidad entre los casos confirmados. Los informes que describen la investigación de estos brotes son de gran importancia cientÃfica y epidemiológica, sin embargo, la información sólo en el primer brote se ha publicado [4]. Por estas razones, se reportan los resultados del cuarto brote de AOACD que ocurrió en Venezuela, en el estado de Táchira.Acute orally acquired Chagas disease (AOACD) has emerged as a significant threat in some countries
of South America [1,2]. Until March 2013, at least
four have reported outbreaks of acute orally acquired Chagas disease, specifically Brazil [3], Venezuela [4], Colombia [5] and Bolivia [6]. Outbreaks are also likely occurring in Argentina and Ecuador, according to some old reports [2]. In Venezuela, there have been at least three well-known epidemiological reports of AOACD, the first in 2007 at Caracas (Chacao) [4], the second in 2009 at Vargas [7] and the third in 2010 at
Caracas (Antimano) [8]. A common feature of these
outbreaks is that they have affected predominantly
children and have led to a high fatality rate among confirmed cases. Reports describing the investigation of these outbreaks are of high scientific and epidemiological significance; however, information on only the first outbreak has been published [4]. For these reasons we report the findings of the fourth outbreak of AOACD that occurred in Venezuela, in Táchira state
Infectious Diseases, Social, Economic and Political Crises, Anthropogenic Disasters and Beyond: Venezuela 2019 – Implications for Public Health and Travel Medicine
During last months, there have been a significant increase in the evidences showing the catastrophic health situation in Venezuela. There are multiple epidemics, increase in emerging and reemerging infectious, tropical and parasitic diseases as consequences of the social, economic and political crises, which would be considered today a clearly anthropogenic disaster. Venezuela is facing in 2019, the worse sanitary conditions, with multiple implications for public health and travel medicine. So far, from a global perspective, this situation will be an impediment for the achievement of the sustainable development goals (SDG) in 2030. In this multiauthor review, there is a comprehensive analysis of the situation for infectious diseases, non-communicable diseases, their impact in the Americas region, given the migration crisis as well as the comparative status of the SDG 2030. This discussion can provide input for prioritizing emerging health problems and establish a future agenda
Yellow fever reemergence in Venezuela – Implications for international travelers and Latin American countries during the COVID-19 pandemic
Fundación Universitaria Autónoma de las Américas. Faculty of Medicine. Grupo de InvestigacÃon Biomedicina. Pereira, Risaralda, Colombia / Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Fundación Universitaria Autónoma de las Américas. Grupo de InvestigacÃon GISCA. Semillero de Zoonosis. Sede Pereira, Pereira, Risaralda,
Colombia / Instituto para la Investigación en Ciencias Biomédicas. Emerging Infectious Diseases and Tropical Medicine Research Group. Pereira, Risaralda, Colombia /
Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Universidad Cientifica
del Sur. Master of Clinical Epidemiology and Biostatistics. Lima, Peru / Institución Universitaria Visión de las Américas. Faculty of Medicine. Grupo de Investigacón Biomedicina. Pereira, Risaralda, Colombia / Institución Universitaria Visión de las Américas. Grupo de Investigación GISCA. Semillero de Zoonosis. Sede Pereira, Pereira, Risaralda, Colombia.Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Fundación Universitaria Autónoma de las Américas. Grupo de InvestigacÃon GISCA. Semillero de Zoonosis. Sede Pereira, Pereira, Risaralda, Colombia / Instituto para la Investigación en Ciencias Biomédicas. Emerging Infectious Diseases and Tropical Medicine Research Group. Pereira, Risaralda, Colombia / Institución Universitaria Visión de las Américas. Grupo de Investigación GISCA. Semillero de Zoonosis. Sede Pereira, Pereira, Risaralda, Colombia.Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Instituto Conmemorativo Gorgas de Estudios de la Salud. Clinical Research Deparment. Investigador SNI Senacyt Panama. Panama City, Panama.Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / University of
Colorado Anschutz Medical Center. Department of Medicine. Division of Infectious Diseases. Aurora, CO, USA / Hospital Infantil de México. Federico Góomez, Méexico City, Mexico.Biomedical Research and Therapeutic Vaccines Institute. Ciudad Bolivar, Venezuela.Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Universidad de Cordoba. Instituto de Investigaciones Biológicas del Trópico. Colombia.Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Hospital
Universitario de Sincelejo. Infectious Diseases and Infection Control Research Group. Sincelejo, Sucre, Colombia / Universidad
del Atlático. SUE Caribe. Programa del Doctorado de Medicina Tropical. Barranquilla, Colombia.Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Universidad Cooperativa de
Colombia. Grupo de Investigación en Ciencias Animales. Bucaramanga, Colombia.Fundación Universitaria Autónoma de las Américas. Faculty of Medicine. Grupo de InvestigacÃon Biomedicina. Pereira, Risaralda, Colombia / Colombian Association of Infectious Diseases. Committe on Tropical Medicine, Zoonoses and Travel Medicine. Bogota, Colombia / Instituto para la Investigación en Ciencias Biomédicas. Emerging Infectious Diseases and Tropical Medicine Research Group. Pereira, Risaralda, Colombia /
Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Fundación Universitaria Autónoma de las Américas. Faculty of Medicine.
Semillero de Investigación en Infecciones Emergentes y Medicina Tropical. Pereira, Risaralda, Colombia / Institución Universitaria Visión de las Américas. Faculty of Medicine. Grupo de Investigacón Biomedicina. Pereira, Risaralda, Colombia.Instituto Médico La Floresta. Caracas, Venezuela.Universidad del Norte
and Hospital Universidad del Norte. Department of Medicine, Health Sciences Division. Barranquilla, Colombia.Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Universidad Central de Venezuela. Faculty of Medicine. Caracas, Venezuela.Institute of Infectious Diseases Emilio Ribas, São Paulo, SP, Brazil.Universidad Estatal del Sur de ManabÃ. Carrera de Laboratorio ClÃnico. Cantón Jipijapa, Ecuador.Universidad Católica del Maule. VicerrectorÃa de Investigación y Postgrado. Chile.Universidad Central de
Venezuela. Faculty of Medicine. Hospital
Universitario de Caracas. Department of Internal Medicine. Cardiology Division. Caracas, Venezuela.Hospital José MarÃa Vargas. La Guaira, Vargas, Venezuela.Universidad Castilla La Mancha. Facultad de Medicina. Complejo Hospitalario Universitario de
Albacete. Servicio de AnatomÃa Patológica. Albacete,
Spain.International Airport Camilo Daza. Health Care Service. Cúcuta, Norte de Santander, Colombia.Universidade de São Paulo. Faculdade de Saúde Pública. Departamento de Epidemiologia. São Paulo, SP, Brazil.Universidad Técnica de Ambato. Ambato, Ecuador.Hospital Transfrontalier Cerdayna. Catalonia, Spain.University of Illinois. Department of Internal Medicine. Division of Infectious Diseases. Chicago, IL, USA.Hospital Evangélico de Montevideo. Montevideo, Uruguay.Universidad Cooperativa de Colombia. Grupo de Investigación en Ciencias Animales. Bucaramanga, Colombia.Instituto Nacional de Salud del Niño San
Borja. Infectious Diseases Division. Lima, Peru / Universidad Privada de Tacna. Facultad de Ciencias de la Salud. Tacna, Peru.Hospital Universitario Departamental de Nariño. Pasto, Nariño, Colombia.Universidad de
Manizales. School of Medicine. Coordination of Microbiology. Manizales, Caldas, Colombia / Grupo de Resistencia Antibiótica de Manizales. Manizales, Caldas, Colombia.ClÃnica San Josée. Cúcuta, Norte de Santander, Colombia /
Hospital Universitario Erasmo Meoz. Cúcuta, Norte de Santander, Colombia.Hospital de Niños J. M. de Los RÃos. Division of Infectious Diseases. Caracas, Venezuela / Venezuelan Society of Infectious Diseases. Executive Board. Caracas, Venezuela.University of Colorado Anschutz Medical Center. Department of Medicine. Division of Infectious Diseases. Aurora, CO, USA.Universidad Industrial de Santander. Department of Internal Medicine. Bucaramanga, Santander, Colombia.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brasil / aq Universidade Federal do Para. Faculdade de Medicina. Belém, PA, Brasil.Hospital de Infecciosas F. MuñÃz. Buenos Aires, Argentina.GSK Vaccines. Clinical Research & Development and Medical Affairs. Rio de Janeiro, RJ, Brazil.Hospital de Trauma y Emergencias Federico Abete. Buenos Aires, Argentina.Hospital Británico de Buenos Aires. Buenos Aires, Argentina.Pontificia Universidad Católica de Chile. School of
Medicine. Department of Pediatric Infectious Diseases and Immunology. Santiago de Chile, Chile.Hospital de Infecciosas F. MuñÃz. Buenos Aires, Argentina.Hospital de Infecciosas F. MuñÃz. Buenos Aires, Argentina / Universidad de Buenos Aires. Buenos Aires, Argentina.Latin American Society for Travel Medicine. Panel of Sports and Travel. Buenos Aires, Argentina.Universidad Internacional SEK. Health Sciences Faculty. Research Group of Emerging Diseases, Ecoepidemiology and Biodiversity. Quito, Ecuador / Universidad Central de Venezuela. Facultad de Ciencias. Instituto de ZoologÃa y EcologÃa Tropical. Caracas, Venezuela.Pan-American Association of Infectious
Diseases. Committe on Travel Medicine. Panama City, Panama / Instituto de Investigaciones Biomédicas. ClÃnica IDB Cabudare. Department of Infectious Diseases and Tropical Medicine. Lara, Venezuela / Venezuelan Science Incubator and the Zoonosis and Emerging Pathogens Regional Collaborative Network. Infectious Diseases Research Branch. Lara, Venezuela / Instituto de Estudios Avanzados. Laboratorio de Señalización Celular y BioquÃmica de Parásitos. Caracas, Caracas, Venezuela / Academia Nacional de Medicina. Caracas, Venezuela / The Mount Sinai Hospital-Icahn School of Medicine at Mount Sinai. Department of Pathology, Molecular and Cellbased Medicine. Direction of Microbiology. New York, USA